These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 24906762)

  • 1. Modified pullulan nanoparticles for oral delivery of lopinavir: formulation and pharmacokinetic evaluation.
    Ravi PR; Vats R; Balija J; Adapa SP; Aditya N
    Carbohydr Polym; 2014 Sep; 110():320-8. PubMed ID: 24906762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A hybrid design to optimize preparation of lopinavir loaded solid lipid nanoparticles and comparative pharmacokinetic evaluation with marketed lopinavir/ritonavir coformulation.
    Ravi PR; Vats R; Dalal V; Murthy AN
    J Pharm Pharmacol; 2014 Jul; 66(7):912-26. PubMed ID: 24697749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation and in-vivo Evaluation of Novel Topical Gel of Lopinavir for Targeting HIV.
    Ansari H; Singh P
    Curr HIV Res; 2018; 16(4):270-279. PubMed ID: 30246641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, optimization and evaluation of poly-ε-caprolactone (PCL) based polymeric nanoparticles for oral delivery of lopinavir.
    Ravi PR; Vats R; Dalal V; Gadekar N; N A
    Drug Dev Ind Pharm; 2015 Jan; 41(1):131-40. PubMed ID: 24180260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pullulan acetate nanoparticles prepared by solvent diffusion method for epirubicin chemotherapy.
    Zhang HZ; Gao FP; Liu LR; Li XM; Zhou ZM; Yang XD; Zhang QQ
    Colloids Surf B Biointerfaces; 2009 Jun; 71(1):19-26. PubMed ID: 19186037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting.
    Aji Alex MR; Chacko AJ; Jose S; Souto EB
    Eur J Pharm Sci; 2011 Jan; 42(1-2):11-8. PubMed ID: 20971188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of Oral Bioavailability of Lopinavir Without Co-administration of Ritonavir Using Microspheres of Thiolated Xyloglucan.
    Madgulkar AR; Bhalekar MR; Kadam AA
    AAPS PharmSciTech; 2018 Jan; 19(1):293-302. PubMed ID: 28717974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic development of solid self-nanoemulsifying oily formulations (S-SNEOFs) for enhancing the oral bioavailability and intestinal lymphatic uptake of lopinavir.
    Garg B; Katare OP; Beg S; Lohan S; Singh B
    Colloids Surf B Biointerfaces; 2016 May; 141():611-622. PubMed ID: 26916320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability enhancement, Caco-2 cells uptake and intestinal transport of orally administered lopinavir-loaded PLGA nanoparticles.
    Joshi G; Kumar A; Sawant K
    Drug Deliv; 2016 Nov; 23(9):3492-3504. PubMed ID: 27297453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative pharmacokinetic evaluation of lopinavir and lopinavir-loaded solid lipid nanoparticles in hepatic impaired rat model.
    Ravi PR; Vats R
    J Pharm Pharmacol; 2017 Jul; 69(7):823-833. PubMed ID: 28317117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability and in vivo evaluation of pullulan acetate as a drug nanocarrier.
    Tang HB; Li L; Chen H; Zhou ZM; Chen HL; Li XM; Liu LR; Wang YS; Zhang QQ
    Drug Deliv; 2010; 17(7):552-8. PubMed ID: 20550433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ionic strength-sensitive pullulan acetate nanoparticles (PAN) for intratumoral administration of radioisotope: ionic strength-dependent aggregation behavior and (99m)Technetium retention property.
    Park KH; Song HC; Na K; Bom HS; Lee KH; Kim S; Kang D; Lee DH
    Colloids Surf B Biointerfaces; 2007 Sep; 59(1):16-23. PubMed ID: 17532195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The preliminary evaluation on cholesterol-modified pullulan as a drug nanocarrier.
    Shen S; Li H; Yang W
    Drug Deliv; 2014 Nov; 21(7):501-8. PubMed ID: 24625263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of folate-modified pullulan acetate nanoparticles for tumor-targeted drug delivery.
    Zhang HZ; Li XM; Gao FP; Liu LR; Zhou ZM; Zhang QQ
    Drug Deliv; 2010 Jan; 17(1):48-57. PubMed ID: 22747075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QbD based development of proliposome of lopinavir for improved oral bioavailability.
    Patel GM; Shelat PK; Lalwani AN
    Eur J Pharm Sci; 2017 Oct; 108():50-61. PubMed ID: 27586019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Darunavir-Loaded Lipid Nanoparticles for Targeting to HIV Reservoirs.
    Desai J; Thakkar H
    AAPS PharmSciTech; 2018 Feb; 19(2):648-660. PubMed ID: 28948564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pullulan-based nanoparticles as carriers for transmucosal protein delivery.
    Dionísio M; Cordeiro C; Remuñán-López C; Seijo B; Rosa da Costa AM; Grenha A
    Eur J Pharm Sci; 2013 Sep; 50(1):102-13. PubMed ID: 23624352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of solid lipid nanoparticles (SLNs) of lopinavir using hot self nano-emulsification (SNE) technique.
    Negi JS; Chattopadhyay P; Sharma AK; Ram V
    Eur J Pharm Sci; 2013 Jan; 48(1-2):231-9. PubMed ID: 23153618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid lipid nanoparticles and nanosuspension formulation of Saquinavir: preparation, characterization, pharmacokinetics and biodistribution studies.
    Dodiya SS; Chavhan SS; Sawant KK; Korde AG
    J Microencapsul; 2011; 28(6):515-27. PubMed ID: 21728760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.